ProBliva Acne Clarifying Body Wash

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: ProBliva Acne Clarifying Body Wash
Generic name: SALICYLIC ACID 1%
Manufacturer: CAVTECH HOLDING LLC
Product type: HUMAN OTC DRUG
SPL set ID: 57e3989f-f4f5-8b5d-e063-6394a90ac4f3
SPL ID: 57e3989f-f4f6-8b5d-e063-6394a90ac4f3
Version: 1
Effective date: 2026-07-31
Source export date: 2026-10-12
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:15:40

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		ProBliva Acne Clarifying Body Wash	openfda.brand_name
generic name		SALICYLIC ACID 1%	openfda.generic_name
manufacturer name		CAVTECH HOLDING LLC	openfda.manufacturer_name
ndc	package	85464-010-01	openfda.package_ndc
ndc	product	85464-010	openfda.product_ndc
ndc11	package	85464001001	derived:openfda.package_ndc
rxcui		1038982	openfda.rxcui
spl id		57e3989f-f4f6-8b5d-e063-6394a90ac4f3	id
spl set id		57e3989f-f4f5-8b5d-e063-6394a90ac4f3	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time. If irritation occurs, noly use one topical acne medication at a time avoid contact with eyes. If contact occurs, rinse thoroughly with water. Stop use and ask a doctor if irritation becomes severe. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.